MARK J. AHN
Associate Professor of Global Management
B.A. Chaminade University
M.B.A. Chaminade University
Ph.D. University of South Australia

EML:  mahn@willamette.edu

Mark J. Ahn, Ph.D. will join the Willamette University faculty in fall 2009. Dr. Ahn is currently Professor and Chair, Science & Technology Entrepreneurship with a joint appointment from the faculties of Commerce & Administration and Science, Victoria University of Wellington; and Principal, Pukana Partners a life sciences strategic consulting firm. 

Prior to Victoria, Dr. Ahn was founder, President, and Chief Executive Officer of Hana Biosciences, Inc. that he led from private to NASDAQ-listed company.  Prior to Hana, he served as Vice President, Hematology and corporate officer at Genentech, Inc. Dr. Ahn also held a series of positions of increasing responsibility at Amgen and Bristol-Myers Squibb Company in general management, strategy, sales & marketing, business development, and finance.

Dr. Ahn also serves on public and private company Boards of Directors for RXi Pharmaceuticals, Access Pharmaceuticals, Periocyte, and Mesynthes.  He also serves on the Board of Governors for Chaminade University.

Dr. Ahn received a BA and MBA from Chaminade University.  He was a graduate fellow in Economics at Essex University, and has a Ph.D. from the University of South Australia. Dr. Ahn is a Henry Crown Fellow at the Aspen Institute.

Dr. Ahn’s teaching and research interests include global strategy and innovation management; biotechnology and life science industries; leadership and transformational change; and social responsibility and venture philanthropy.

Ahn, M., Davenport, S., Meeks, M. & Bednarek, R. 2009. Exploring Technology Agglomeration Patterns for Multinational Pharmaceutical and Biotechnology Firms, Journal of Commercial Biotechnology.

Ahn, M. & York, A. 2009. Resource- and institution-based approaches to biotechnology industry development in Malaysia, Asia Pacific Journal of Management.

Ahn, M., Meeks, M., Davenport, S. & Bednarek, R. 2009. Death of Distance?: Biotechnology Agglomeration Patterns, Alliance Proximity, and Firm Performance, International Journal of Innovation and Technology Management.

Ahn, M. & Meeks, M. 2008. Building a Conducive Environment for Life Science Based Entrepreneurship and Industry Clusters, Journal of Commercial Biotechnology.

Ahn, M., Meeks, M., & Bednarek, R. 2008.Managing High Growth (Ad)Ventures: Putting Good Advice to Work in New Zealand Firms, Deloitte & Touche Research Series.

Ahn, M., Ackerley, D., Davenport, S., & Bednarek, R. 2008. Industrial Research Limited: New Zealand-Based Biopharmaceutical Entrepreneurship, The Management Case Study Journal.

Ahn, M., Meeks, M., Ross, C., Bednarek, R. & Dalziel, S. 2008. Making Biotechnology Work for New Zealand, NZBIO-GW Research Series.

Ahn, M., Vitale, F. & Tong, V. 2005. Biopharmaceutical Alliances: It’s All Academic, Biopharmaceutical International.

Ahn, M. & Dornbusch, D. 2004. From Leaders and Leadership: Managing Change, Journal of Leadership and Organizational Studies. \

Ahn, M. & Dornbusch, D. 2003. Competency-Based Benchmarking: Revolutionizing Biopharmaceutical Product Launches, Benchmarking: An International Journal.

Ahn, M., Grimwood, A., Schwarzwald, H. & Herman, A. 2003.  Ethics and the HIV/AIDS Pandemic in the Developing World, Journal of International Association of Physicians in AIDS Care.

Ahn, M., Damonti, J. & Herman, A. 2000. Public Private Partnerships in Healthcare for Developing Countries: A New Paradigm for Change, Managed Care Quarterly.

Ahn, M. 1999. Developing a Profitable Market Share Strategy for Multinational Pharmaceutical Companies in China, Journal of Pharmaceutical Marketing & Management.